Sinusitis
134
3
8
86
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
33 trials with published results (25%)
Research Maturity
86 completed trials (64% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.5%
10 terminated out of 134 trials
89.6%
+3.0% vs benchmark
27%
36 trials in Phase 3/4
38%
33 of 86 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 86 completed trials
Clinical Trials (134)
Dupilumab in CRSsNP
Comparative Effectiveness of Available Treatments for Sinus and Ear Infections in Children (Acute Sinusitis)
High Resolution Micro OCT Imaging
Clinical Outcomes and Patient Satisfaction With Velnez Versus Nasopore in Nasal Surgery
Endoscopic Assessment of Schneiderian Membrane Perforation During Osseodensification-mediated Transcrestal Sinus Floor Elevation With Graftless Immediate Implant Placement in Subsinus Bone Height of 4-6 mm: A Pilot Study.
Complicated Infections in Otorhinolaryngology
Reducing Antibiotic Use by Implementation of Stewardship in Primary and Urgent Care
Best Practice in the Management of Concha Bullosa in FESS Operation
Harnessing Digital Medicine to Improve Allergic Rhinitis Management in Primary Care (DMAR)
Application of Ectoin® Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis
Pilot Study of The EPIC Trial
In-clinic Endoscopic Polypectomy for Chronic Sinusitis With Nasal Polyps
A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps
Using ChatGPT to Help Guide Treatment for Sinus and Nasal Problems
A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
Dupixent Study for Alternate Administration
Clinical Study of Safety and Efficacy for the Relieva Stratus With Elution of Triamcinolone Acetonide
Optimization and Refinement of Technique in In-Office Sinus Dilation 2
Efficacy of Two Nasal Products Based on Diluted Seawater in the Treatment of Upper Respiratory Infections/Conditions